Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Interesting statement made in HEXO's financials

<< Previous

Bullboard Posts

Next >>

Comment by mdjbrownon Dec 16, 2022 10:10am

166 Views

Post# 35175555

RE:RE:RE:RE:Interesting statement made in HEXO's financials

You are very welcome checkup

It was encouraging to see that HEXO acknowledges the debt owed and that there is willingness to settle this debt owed.

HEXO'S appeal filed in August will take time to work its way through the courts, but I would think HEXO is now on the clock for continued interest on the $9.8 million, and even at one percent interest, each passing day adds significantly to that total.

Maybe thats why HEXO just announced a 14 to 1 share consolidation, as they are trying to get their financial boat afloat..........

A transfer of $8,530 owed to a cannabis supplier into settlement liabilities and onerous contracts as the result of a legal judgement;

Management has initiated an appeal against the court’s decision and is simultaneously pursuing a settlement with the counterparty.”